<DOC>
	<DOCNO>NCT01801072</DOCNO>
	<brief_summary>After thorough review exist literature well review practice , investigator conclude decision treat patient undergoing aneurysm repair levetiracetam reach true clinical equipoise . In word , investigator favor decision either administer administer drug patient base exist information . The utility anti-epileptic prophlaxis perioperative period patient undergoing intracranial aneurysm repair remain common practice support current literature include retrospective analysis well prospective trial similar identical type patient . The investigator propose settle dilemma perform prospective randomize trial patient undergoing aneurysm repair order definitively determine common practice perioperative antiepileptic drug administration utility .</brief_summary>
	<brief_title>Seizure Prophylaxis Aneurysm Repair</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Intracranial Aneurysm</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>Adult ( â‰¥18 year ) Presence intracranial aneurysm ( without rupture ) Treating surgeon recommend surgical repair aneurysm History seizure within last 10 year History epilepsy History prior stroke Currently prescribe medication antiepileptic activity ( keppra , dilantin , tegretol , lamictal , topamax , etc . ) Brain tumor Pregnant nursing woman Known levetiracetam allergy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>